Business Of Biotech cover image

Multimodal R&D Management with Incyte's Jim Lee, M.D., Ph.D.

Business Of Biotech

CHAPTER

Introduction

Dr. Jim Lee, Group VP and Head of Inflammation and Autoimmunity at in-site, discusses the company's success and pipeline progress in oncology, inflammation, blood disorders, and GVHD portfolios, providing insights into managing R&D in a large multimodal and multi-indication company.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner